Serum Micro-RNA-122 Level as a Simple Noninvasive Marker of MAFLD Severity
Mona A Hegazy,1 Ibrahim Abd ALgwad,1 Soheir Abuel Fadl,1 Mohamed Sayed Hassan,1 Laila Ahmed Rashed,2 Maha A Hussein1 1Internal Medicine Department, Kasr Al-Aini Hospitals, Cairo University, Cairo, Egypt; 2Biochemistry Department, Kasr Al-Aini Hospitals, Cairo University, Cairo, EgyptCorrespondence:...
Main Authors: | Hegazy MA, Abd ALgwad I, Abuel Fadl S, Sayed Hassan M, Ahmed Rashed L, Hussein MA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-05-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/serum-micro-rna-122-level-as-a-simple-noninvasive-marker-of-mafld-seve-peer-reviewed-fulltext-article-DMSO |
Similar Items
-
Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitis
by: Chung‐Feng Huang, et al.
Published: (2024-04-01) -
PREVENTIVE ZINC SUPPLEMENTATION EFFECT ON REDOX STATUS IN RAT MODEL OF MAFLD
by: Eugenia R. Nikonorova, et al.
Published: (2023-02-01) -
Clinical Progression of Metabolic-Associated Fatty Liver Disease Is Rare in a Danish Tertiary Liver Center
by: Tea Lund Laursen, et al.
Published: (2022-04-01) -
Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease
by: Patrice Marques, et al.
Published: (2023-01-01) -
MAFLD: How is it different from NAFLD?
by: Cameron Gofton, et al.
Published: (2023-02-01)